Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer ...

The Colorectal Cancer Resource & Action Network (CCRAN) announced the release of new research in collaboration with The Conference Board of Canada (CBoC), revealing how universal access to an advanced ...

Is Galleri the future of cancer treatment? It's not that simple. The new research from the company, while promising, isn't ...

Investigators analyzed exfoliated cells in urine test specimens to identify 50 candidate RNAs for prostate cancer detection.

SimplyTest (R) is proud to announce a new partnership with Evexia Diagnostics, a premier provider of diagnostic laboratory services for functional and integrative medicine. Through this collaboration, ...

Diagnostic testing is big business. The global market for testing semiconductors for defects is estimated at $39 billion in 2025. For medical lab tests, the market is even bigger: $125 billion.

Since its launch in January 2024, the initiative has achieved significant milestones across 5 key pillars -- Community Outreach, Action Against Non-Communicable Diseases (NCDs), Training & Capacity ...

EMVision CEO and managing director Scott Kirkland reflects on what has been a big year, with the medtech steadily achieving ...

The Korea Research Institute of Standards and Science (KRISS) has developed a retina-mimicking eye phantom that faithfully ...

A Norwegian public transport operator plans to tighten security after tests on Chinese-made electric buses revealed the ...

On Oct. 31, the National Veterinary Services Laboratories confirmed findings of vesicular stomatitis New Jersey virus (VSNJV) ...

Experts worry early detection tests like Galleri and CancerGuard are unproven and could drive up health care costs by ...